157 related articles for article (PubMed ID: 24837412)
21. Direct Detection of Erythromycin-Resistant Bordetella pertussis in Clinical Specimens by PCR.
Wang Z; Han R; Liu Y; Du Q; Liu J; Ma C; Li H; He Q; Yan Y
J Clin Microbiol; 2015 Nov; 53(11):3418-22. PubMed ID: 26224847
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China.
Hua CZ; Wang HJ; Zhang Z; Tao XF; Li JP; Mi YM; Tang LF; Chen ZM
J Glob Antimicrob Resist; 2019 Sep; 18():47-51. PubMed ID: 30710647
[TBL] [Abstract][Full Text] [Related]
23. Modifying antibiotic treatment strategies in the face of pertussis surge associated to erythromycin resistance in China.
Shi W; Meng Q; Hu Y; Yao K
J Infect; 2024 Jun; 88(6):106174. PubMed ID: 38719109
[No Abstract] [Full Text] [Related]
24. State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.
Hoppe JE
Infection; 1998; 26(4):242-6. PubMed ID: 9717684
[No Abstract] [Full Text] [Related]
25. Pharmacotherapy for Bordetella pertussis infection. II. A synthesis of clinical sciences.
Cimolai N
Int J Antimicrob Agents; 2021 Mar; 57(3):106257. PubMed ID: 33310117
[TBL] [Abstract][Full Text] [Related]
26. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 Nov; 43(44):807-10. PubMed ID: 7968996
[TBL] [Abstract][Full Text] [Related]
27. From the Centers for Disease Control and Prevention. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.
JAMA; 1995 Jan; 273(1):13-4. PubMed ID: 7996637
[No Abstract] [Full Text] [Related]
28. High-resolution melting analysis for the detection of two erythromycin-resistant Bordetella pertussis strains carried by healthy schoolchildren in China.
Zhang Q; Li M; Wang L; Xin T; He Q
Clin Microbiol Infect; 2013 Jun; 19(6):E260-2. PubMed ID: 23480481
[TBL] [Abstract][Full Text] [Related]
29. Challenges and prospects in treating macrolide-resistant Bordetella pertussis in Chinese paediatric practice.
Yang R; Xu H; Zhang Z; Liu Q; Wu X
J Infect; 2024 Jul; 89(1):106185. PubMed ID: 38763390
[No Abstract] [Full Text] [Related]
30. Progressive respiratory distress in an infant treated for presumed pertussis.
Lee B
Pediatr Infect Dis J; 2000 May; 19(5):475, 492-3. PubMed ID: 10819348
[No Abstract] [Full Text] [Related]
31. Differential in vitro expression of the brkA gene in Bordetella pertussis and Bordetella parapertussis clinical isolates.
Stefanelli P; Sanguinetti M; Fazio C; Posteraro B; Fadda G; Mastrantonio P
J Clin Microbiol; 2006 Sep; 44(9):3397-400. PubMed ID: 16954284
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of whooping cough & typing of Bordetella pertussis.
Hegerle N; Guiso N
Future Microbiol; 2013 Nov; 8(11):1391-403. PubMed ID: 24199799
[TBL] [Abstract][Full Text] [Related]
33. [Bordetella pertussis: a case of whooping cough in a newborn].
Ben Hassine A; Bejaoui M; Lakhoua M; Ben Redjeb S
Tunis Med; 1994 Dec; 72(12):719-22. PubMed ID: 7624981
[No Abstract] [Full Text] [Related]
34. Azithromycin for the treatment of pertussis.
Pichichero ME; Hoeger WJ; Casey JR
Pediatr Infect Dis J; 2003 Sep; 22(9):847-9. PubMed ID: 14515842
[No Abstract] [Full Text] [Related]
35. Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.
Appleman ME; Hadfield TL; Gaines JK; Winn RE
Diagn Microbiol Infect Dis; 1987 Oct; 8(2):131-3. PubMed ID: 2892608
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of fluoroquinolones against erythromycin-susceptible and -resistant Bordetella pertussis.
Bourgeois N; Ghnassia JC; Doucet-Populaire F
J Antimicrob Chemother; 2003 Mar; 51(3):742-3. PubMed ID: 12615884
[No Abstract] [Full Text] [Related]
37. A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents.
Hill BC; Baker CN; Tenover FC
J Clin Microbiol; 2000 Mar; 38(3):1151-5. PubMed ID: 10699011
[TBL] [Abstract][Full Text] [Related]
38. Phenotypical and genotypical characterization of Bordetella pertussis strains isolated in São Paulo, Brazil, 1988-2002.
Gonçalves CR; Vaz TM; Medeiros MI; Castro MT; Rocha MM; Melles CE; Irino K
Rev Inst Med Trop Sao Paulo; 2007; 49(2):123-5. PubMed ID: 17505674
[TBL] [Abstract][Full Text] [Related]
39. Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005-2009.
Bokhari H; Said F; Syed MA; Mughal A; Kazi YF; Heuvelman K; Mooi FR
Scand J Infect Dis; 2011 Oct; 43(10):818-20. PubMed ID: 21563881
[TBL] [Abstract][Full Text] [Related]
40. Clinical manifestations of children with microbiologically confirmed pertussis infection and antimicrobial susceptibility of isolated strains in a regional hospital in Japan, 2008-2012.
Horiba K; Nishimura N; Gotoh K; Kawaguchi M; Takeuchi S; Hattori F; Isaji M; Okai Y; Hosono H; Takemoto K; Ozaki T
Jpn J Infect Dis; 2014; 67(5):345-8. PubMed ID: 25241683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
